Sequoia Financial Advisors LLC Acquires 3,568 Shares of UnitedHealth Group Incorporated $UNH

Sequoia Financial Advisors LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 6.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 57,701 shares of the healthcare conglomerate’s stock after purchasing an additional 3,568 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in UnitedHealth Group were worth $19,048,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of UnitedHealth Group by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 91,600,260 shares of the healthcare conglomerate’s stock worth $30,238,162,000 after purchasing an additional 995,210 shares during the period. Capital World Investors lifted its stake in shares of UnitedHealth Group by 18.8% during the 3rd quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock valued at $7,516,107,000 after buying an additional 3,439,182 shares in the last quarter. Capital International Investors increased its stake in UnitedHealth Group by 11.1% in the 3rd quarter. Capital International Investors now owns 17,499,949 shares of the healthcare conglomerate’s stock worth $6,042,710,000 after buying an additional 1,747,337 shares in the last quarter. Capital Research Global Investors lifted its position in shares of UnitedHealth Group by 126.9% in the third quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock valued at $4,503,419,000 after acquiring an additional 7,293,009 shares in the last quarter. Finally, Dodge & Cox grew its position in shares of UnitedHealth Group by 8.6% during the third quarter. Dodge & Cox now owns 9,505,636 shares of the healthcare conglomerate’s stock worth $3,282,296,000 after purchasing an additional 755,076 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at $6,320,775. The trade was a 4.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $367.11 on Thursday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $395.52. The company has a market capitalization of $333.41 billion, a PE ratio of 27.73, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64. The stock’s fifty day moving average is $302.62 and its two-hundred day moving average is $316.89. The company has a quick ratio of 0.79, a current ratio of 0.80 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm had revenue of $111.65 billion during the quarter, compared to analyst estimates of $109.84 billion. During the same period in the previous year, the firm earned $7.20 earnings per share. The business’s revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were issued a $2.21 dividend. The ex-dividend date was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group’s payout ratio is presently 66.77%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on UNH. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 target price on the stock in a research report on Tuesday, April 7th. TD Cowen boosted their price objective on UnitedHealth Group from $311.00 to $337.00 and gave the stock a “hold” rating in a research note on Thursday, April 23rd. Jefferies Financial Group lifted their target price on UnitedHealth Group from $340.00 to $373.00 and gave the stock a “buy” rating in a report on Monday, April 20th. Weiss Ratings downgraded UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, March 2nd. Finally, Oppenheimer boosted their price objective on shares of UnitedHealth Group from $385.00 to $405.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $378.88.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Zacks Research raised near‑term and FY‑2026 EPS forecasts (Q2 2026 to $4.94 from $4.74; FY‑2026 to $18.26), signaling stronger near‑term earnings momentum and reinforcing consensus that 2026 will be a recovery year. (Zacks estimate revisions — MarketBeat / summary)
• Positive Sentiment: UnitedHealthcare will eliminate prior‑authorization requirements for roughly 30% of services starting in 2026 — a large operational change that should reduce administrative friction, improve member/provider experience and potentially lower costs over time. This is being viewed favorably by the market. UnitedHealth Prior Authorization Shift And What It Could Mean For UNH Stock
• Positive Sentiment: Goldman Sachs added UNH to its U.S. Conviction List and kept a $435 price target — a high‑profile vote of confidence that likely supports buying interest. Goldman Sachs Names UnitedHealth (UNH) to Conviction List, Keeps $435 Price Target
• Positive Sentiment: Managerial actions and fundamentals: analysts and commentators point to increased share buybacks and an improved Q1 that lifted guidance — themes that support multiple expansion and investor confidence. Why UnitedHealth Group Stock Came Roaring Back In April
• Neutral Sentiment: Sector context — peers Tenet (THC) beat Q1 but face payer‑mix pressure, and CVS reported strong Health Benefits results tied to ACA exits/premium actions; these moves can influence industry pricing and utilization dynamics but are not direct UNH fundamentals. THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups ’26 EPS View CVS Stock Breaks Out On Earnings Due To ACA Exit, Premium Hikes
• Neutral Sentiment: Talent movement: a former UnitedHealth executive, Heather Cianfrocco, was appointed COO at Highmark — notable for industry networking but not currently viewed as material to UNH’s strategy. Highmark Health Appoints Heather Cianfrocco as Chief Operating Officer
• Negative Sentiment: Zacks also trimmed a few longer‑term quarter/year estimates (small cuts to FY‑2027 and Q1‑2028), which could temper upside expectations for distant‑out periods even as near‑term outlook improved.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.